Pediatric Tinea Capitis: A Retrospective Cohort Study from 2010 to 2021
Journal of Fungi · 17.03.2023 · 9 (3) · 366
DOI: 10.3390/jof9030366 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Fungi, online erschienen am 17.03.2023. Verfasst von Joel Dascalu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Rambam Health Care Campus, Haifa 3525408, Israel. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pediatric tinea capitis displays a wide range of prevalence, with significant variability among populations. We retrospectively extracted the medical records of 456 pediatric patients diagnosed with tinea capitis during the years 2010–2021, from the dermatology outpatient clinics in two tertiary medical centers. Three species were isolated in 90% of patients: T. tonsurans, M. canis, and T. violaceum. While T. tonsurans presented a six-fold increase in incidence during the years 2019–2021, M. canis maintained stable incidence rates. Furthermore, terbinafine was the most efficient antifungal agent against T. tonsurans, achieving complete clinical clearance in 95% of patients, as compared to fluconazole (68%) and griseofulvin (38%) (p < 0.001). The mycological cure was recorded in 61/90 (68%) of patients with available data, at an average of 10 weeks. For patients with M. canis, griseofulvin and fluconazole were equally efficient (73% and 66%, respectively) (p = 0.44). Kerion was described in 36% and 14% of patients with T. tonsurans and M. canis, respectively, (p < 0.001). In conclusion, since 2019, there has been a significant increase in the prevalence of T. tonsurans, establishing this pathogen as the most common cause for tinea capitis in our population. Our data suggest that terbinafine is effective and presents high cure rates for tinea capitis in the pediatric population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Rambam Health Care Campus, Haifa 3525408, Israel.
- Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva 4920235, Israel.
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 3525422, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel.
ORCID-Profile: Joel Dascalu, Emily Avitan-Hersh
Zitieren
APA
Dascalu, J., Zaaroura, H., Renert-Yuval, Y., Khamaysi, Z., Avitan-Hersh, E., & Friedland, R. (2023). Pediatric Tinea Capitis: A Retrospective Cohort Study from 2010 to 2021. Journal of Fungi, 9(3), 366. https://doi.org/10.3390/jof9030366
Vancouver
Dascalu J, Zaaroura H, Renert-Yuval Y, Khamaysi Z, Avitan-Hersh E, Friedland R. Pediatric Tinea Capitis: A Retrospective Cohort Study from 2010 to 2021. Journal of Fungi. 2023;9(3):366. doi:10.3390/jof9030366
BibTeX
@article{Dascalu2023,
author = {Dascalu, Joel and Zaaroura, Hiba and Renert-Yuval, Yael and Khamaysi, Ziyad and Avitan-Hersh, Emily and Friedland, Rivka},
title = {Pediatric Tinea Capitis: A Retrospective Cohort Study from 2010 to 2021},
journal = {Journal of Fungi},
year = {2023},
volume = {9},
number = {3},
pages = {366},
doi = {10.3390/jof9030366}
}
EUVIMED